Literature DB >> 16334803

High CD40 expression in gastric cancer associated with expanding type histology and liver metastasis.

Su-Shun Lo1, Chew-Wun Wu, Chin-Wen Chi, Anna F Y Li, Jen-Hao Chen, Wing-Yiu Lui.   

Abstract

BACKGROUND/AIMS: We have previously reported higher serum TNF-alpha levels in some gastric cancer patients. The status of its receptor (CD40 expression) in gastric cancer tissue and their clinical relevance is worthy of study.
METHODOLOGY: The expression of CD40 was examined immunohistochemically in 32 gastric carcinoma specimens and graded as high and low expressions according to the proportion of stained tumor cells. The clinicopathological factors including age, sex, tumor location, size, gross appearance, stromal reaction pattern, degree of cellular differentiation, histological classification, depth of tumor invasion, lymph node status, peritoneal dissemination, liver metastasis and TNM stage were analyzed according to the different expression of CD40.
RESULTS: There were 18 patients with low CD40 expression and 14 patients with high CD40 expression. There were more expanding type tumors than infiltrating type by Ming's histological classification (57.1% vs. 16.7%, p=0.027) and liver metastasis (28.6% vs. 0, p=0.028) in the high expression group. The patient survival showed a worse tendency in patients with high CD40 expression, but did not reach statistical difference. There was no correlation between CD40 expression level and other clinicopathological features.
CONCLUSIONS: The fact that high CD40 expression existed more in expanding type tumor and had more liver metastasis suggests CD40 may play an important role in local invasion mode and hematogenous spread.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16334803

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  4 in total

1.  Efficacy of RAD001 (everolimus) against advanced gastric cancer with peritoneal dissemination.

Authors:  Fumiko Taguchi; Yasuo Kodera; Yasufumi Katanasaka; Kazuyoshi Yanagihara; Tomohide Tamura; Fumiaki Koizumi
Journal:  Invest New Drugs       Date:  2010-06-08       Impact factor: 3.850

2.  CD40 signal expression in gastric cancer tissue and its correlation with prognosis of gastric cancer patients.

Authors:  Rui Li; Wei-Chang Chen; Xue-Qin Pang; Wen-Yan Tian; Wei-Peng Wang; Xue Guang Zhang
Journal:  Mol Biol Rep       Date:  2012-06-22       Impact factor: 2.316

3.  CD40 expression and its prognostic significance in human gastric carcinoma.

Authors:  Jing Guo; Jia-Jia Xiao; Xiaoli Zhang; Kai-Xi Fan
Journal:  Med Oncol       Date:  2015-02-10       Impact factor: 3.064

4.  CD40 mutant expression and its clinical significance to prognosis in gastric cancer patients.

Authors:  Wei-Qing Zhao; Xiao-Dong Li; Hong-Bing Shi; Jun Wu; Jie-Min Zhao; Mei Ji; Chang-Ping Wu
Journal:  World J Surg Oncol       Date:  2014-05-28       Impact factor: 2.754

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.